Loading
AMEXHealthcareMedical - Instruments & Supplies
Latest quote
$0.662
−$0.0288 · -4.17%
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Latest quote
$0.662
−$0.0288 · -4.17%
Regular session · ET · Market data may be delayed.
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Day range
Current $0.662
52-week range
Current $0.662
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
61
Undervalued
Sentiment
52
Mixed
Risk
62
High Risk
Momentum
33
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Day range
Current $0.662
52-week range
Current $0.662
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 38.27M USD | 33.05M USD | 43.6M USD | 94.82M USD | 188.38M USD |
| Cost of goods sold | 38.22M USD | 34.08M USD | 34.49M USD | 66.57M USD | 93.03M USD |
| Gross profit | 47.05K USD | −1.03M USD | 9.11M USD | 28.25M USD | 95.35M USD |
| Research and development | 675.57K USD | 673.94K USD | 581.17K USD | 525.73K USD | 901.38K USD |
| Selling, general, and administrative | 19.59M USD | 19.4M USD | 20.01M USD | 28.58M USD | 21.86M USD |
| Operating expenses | 20.27M USD | 20.08M USD | 20.6M USD | 29.11M USD | 22.76M USD |
| Interest income | 547.36K USD | 1M USD | 1.45M USD | 9.95K USD | 266.47K USD |
| Interest expense | 87.9K USD | 122.5K USD | 152.17K USD | 170.65K USD | 227.18K USD |
| Depreciation and amortization | 7.77M USD | 7.57M USD | 7.53M USD | 4.6M USD | 1.26M USD |
| Operating income | −20.22M USD | −21.11M USD | −11.49M USD | −852.98K USD | 72.6M USD |
| Net income | −12.57M USD | −11.89M USD | −7.01M USD | 5.08M USD | 56.06M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
